Loading clinical trials...

Matrifen® for Therapy of Severe Chronic Pain® | Clinical Trials | Clareo Health

COMPLETED

Matrifen® for Therapy of Severe Chronic Pain®

Efficacy of Matrifen® in Patients Older Than 18 Years With Severe, Chronic Pain Including Quality of Life Questionnaire

NCT00699335•Nycomed

Summary

The aim of the study was to evaluate the efficacy and safety of Matrifen® in patients with severe and chronic pain who could only be sufficiently treated with opioid analgetics (WHO class 3).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Outpatients with severe, chronic pain

Exclusion Criteria

•Hypersensitivity to fentanyl
•Co-administration of monoamineoxidase-inhibitors
•Pregnancy
•Respiratory depression
•Chronic obstructive pulmonary disease (COPD)
•Drug abuse
•Impairment of CNS functions
•Other criteria as defined in the Summary of Product Characteristics (Chapter 4.3)

Locations (1235)

Nycomed Deutschland GmbH

Aalen, Germany

Nycomed Deutschland GmbH

Abensberg, Germany

Nycomed Deutschland GmbH

Adelebsen, Germany

Nycomed Deutschland GmbH

Ahaus, Germany

Nycomed Deutschland GmbH

Ahlen, Germany

Nycomed Deutschland GmbH

Ahrensburg, Germany

Nycomed Deutschland GmbH

Albstadt, Germany

Nycomed Deutschland GmbH

Aldenhoven, Germany

Nycomed Deutschland GmbH

Alfeld, Germany

Nycomed Deutschland GmbH

Alfhausen, Germany

Key Dates

Start Date

June 1, 2008

Primary Completion Date

July 1, 2009

Last Updated

May 8, 2012

Enrollment

5,308

ACTUAL participants

Conditions

Severe Chronic Pain

Interventions

Fentanyl

DRUG

Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain

NCT01709214

Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

View study

COMPLETEDPHASE2

A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects

NCT01915147

Severe Chronic Pain

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 8, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions